Cohen & Steers Inc Form 4 Filings

Cohen & Steers, Inc. reported insider equity activity by CEO and director Joseph M. Harvey. On January 30, 2026, the company withheld 33,644 shares of common stock at $64.58 per share to cover his tax obligations upon vesting of previously reported RSUs.

On the same date, he was granted 80,984 restricted stock units (RSUs) at $0 as the mandatorily deferred portion of his 2025 annual incentive performance bonus. These RSUs vest ratably over four years, and related dividend RSUs vest on the fourth anniversary of the grant date. After these transactions, he directly beneficially owned 1,335,772 shares and had 305,000 shares held indirectly through a limited liability company owned by a family trust, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Cohen & Steers Executive Vice President Daniel Noonan reported equity compensation changes on January 30, 2026. The company withheld 935 shares of common stock at $64.58 per share to cover his tax obligations when previously granted restricted stock units (RSUs) vested and delivered common stock.

On the same date, he received 13,627 new RSUs as the mandatorily deferred portion of his 2025 annual incentive performance bonus, at a stated price of $0 per share. These RSUs vest in equal installments over four years, while any dividend-equivalent RSUs vest on the fourth anniversary of the grant. Following these transactions, he directly held 34,920 common shares and indirectly held 895 shares through the Daniel A. Noonan Revocable Trust, where he serves as trustee.

Cohen & Steers, Inc. reported an equity grant to one of its directors. On 01/02/2026, the director acquired 436 shares of common stock at a price of $0, increasing their holdings to 23,591 shares held directly.

The filing explains that these 436 shares reflect common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the related shares are scheduled to be delivered to the director on the third anniversary of the grant date. This is a routine insider compensation transaction rather than an open-market stock purchase.

Cohen & Steers, Inc. reported an equity award to one of its directors. On 01/02/2026, the director received 436 shares of common stock, recorded at a price of $0 because the shares relate to restricted stock units granted as compensation rather than a market purchase.

After this grant, the director beneficially owns 16,621 shares of Cohen & Steers common stock in direct form. The filing explains that the 436 shares represent common stock underlying restricted stock units that were 100% vested on the grant date, with the actual delivery of the related shares scheduled for the third anniversary of the grant date.

Cohen & Steers, Inc. director and 10% owner Martin Cohen reported changes in his ownership of the company’s common stock. Following the reported activity, he beneficially owned 949,641 shares directly and 8,071,461 shares indirectly through the Martin Cohen 2018 Revocable Trust.

The filing shows an acquisition of 436 shares of common stock at a price of $0. These shares relate to restricted stock units granted by the company that were 100% vested on the grant date. The explanation notes that the related common shares will be delivered to the reporting person on the third anniversary of the grant date. Mr. Cohen disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest.

Cohen & Steers, Inc. director reports stock award and trust transfer

A Cohen & Steers, Inc. director reported equity transactions in the company’s common stock. On 01/02/2026, the director acquired 436 shares of common stock at a price of $0, representing shares underlying restricted stock units that were fully vested on the grant date and scheduled to be delivered on the third anniversary of that grant. Following this, the director directly held 5,025 shares.

On 01/05/2026, the director transferred 419 shares of common stock to the Edmond Dennis Villani Revocable Trust and also reported that this trust held 30,678 shares after the transfer. After these transactions, the director directly held 4,606 shares and indirectly held additional shares through the revocable trust, for which the director and a family member serve as trustees.

Cohen & Steers, Inc. reported an equity grant to one of its directors. On 01/02/2026, the director acquired 436 shares of Cohen & Steers common stock at a price of $0, bringing their total beneficial ownership to 2,003 shares held directly.

The 436 shares represent common stock underlying restricted stock units that were 100% vested on the grant date. The filing explains that the related shares will be delivered to the director on the third anniversary of the grant date, meaning the director has earned the award but will receive the actual shares in the future.

Cohen & Steers, Inc. director reports stock-based award in a recent insider transaction. On 01/02/2026, a director of Cohen & Steers, Inc. (CNS) acquired 436 shares of common stock at a price of $0, reflecting the settlement terms of a stock-based grant rather than an open-market purchase.

The filing explains that these shares represent common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the related shares will be delivered to the director on the third anniversary of the grant date. Following this transaction, the director beneficially owns 9,474 shares of Cohen & Steers common stock in direct ownership form.

Cohen & Steers, Inc. reported a routine insider equity grant for one of its directors. On 01/02/2026, the director acquired 436 shares of Cohen & Steers common stock at a price of $0 per share, increasing the director’s beneficial ownership to 1,738 shares held directly.

The filing explains that these 436 shares represent common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the underlying shares are scheduled to be delivered to the director on the third anniversary of the grant date.

Cohen & Steers, Inc. (CNS) reported an insider equity transaction by its Chief Executive Officer and director. On 11/20/2025, the reporting person acquired 1,401 shares of common stock at a price of $0, reported as an acquisition of dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend and accruing on previously granted unvested restricted stock units from January 2022, 2023, 2024 and 2025.

Following this transaction, the reporting person directly beneficially owns 1,288,432 shares of common stock. In addition, 305,000 shares are held indirectly through a limited liability company owned by a family trust, for which the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.

Cohen & Steers, Inc. (CNS) executive vice president reported an automatic share-based accrual tied to company dividends. On 11/20/2025, the officer acquired 220 shares of common stock at a price of $0, reflecting dividend equivalent restricted stock units credited in connection with the issuer's fourth quarter 2025 dividend. These units accrued on unvested restricted stock units previously granted in June 2024 and January 2025. Following this transaction, the officer beneficially owned 23,123 shares of Cohen & Steers common stock, held directly.

Cohen & Steers, Inc. (CNS) reported a routine insider equity award for its Chief Operating Officer and Executive Vice President on a Form 4. On 11/20/2025, the officer acquired 227 shares of common stock at a price of $0. These shares are described as dividend equivalent restricted stock units that accrued on earlier unvested restricted stock unit grants from January 2022, January 2023, January 2024 and January 2025 in connection with the company’s fourth quarter 2025 dividend. After this transaction, the officer beneficially owns 528,903 shares of Cohen & Steers common stock, held directly. This filing reflects compensation-related accruals rather than an open-market purchase or sale.

Cohen & Steers, Inc. (CNS) executive vice president reported acquiring 68 shares of common stock on 11/20/2025 at a price of $0 per share. The shares reflect dividend equivalent restricted stock units credited in connection with the company's fourth quarter 2025 dividend on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.

Following this transaction, the executive directly beneficially owns 10,314 CNS shares. No derivative securities transactions were reported.

Cohen & Steers, Inc. (CNS) reported a Form 4 transaction for its Interim CFO and SVP. On 11/20/2025, the officer acquired 187 shares of common stock at a price of $0. These shares represent dividend equivalent restricted stock units credited in connection with the company’s fourth quarter 2025 dividend on previously granted unvested restricted stock units from May 2023, January 2024, January 2025 and October 2025. After this transaction, the officer beneficially owns 26,205 shares of Cohen & Steers common stock directly.

Cohen & Steers, Inc. (CNS) reported an insider transaction by Executive Chairman, director and 10% owner Robert H. Steers. On 11/19/2025, trusts associated with him bought additional CNS common stock in open-market purchases.

The Robert H. Steers 2018 Revocable Trust acquired 19,000 shares at a weighted average price of $59.88, bringing its reported beneficial ownership to 7,147,497 shares. The Hilltop GST Non-Exempt Descendants' Trust acquired 6,000 shares at a weighted average price of $59.86, for a reported 3,897,184 shares held after the transaction.

Additional indirect holdings include 805,920 shares held by The Sunnyridge GST Exempt Family Trust and 334 shares held by the Hamilton-Steers 2017 Trust FB Robert H. Steers, plus 139,747 shares reported as directly owned. The filing notes that Mr. Steers disclaims beneficial ownership of certain trust-held shares except to the extent of his pecuniary interest.

Cohen & Steers, Inc. insider equity update: A company officer, serving as Chief Accounting Officer and Senior Vice President, reported an automatic acquisition of 46 shares of Cohen & Steers common stock on 11/20/2025. These shares were received at a price of $0 as dividend equivalent restricted stock units tied to the issuer's fourth quarter 2025 dividend.

These dividend equivalents accrued on unvested restricted stock units originally granted in January 2022, January 2023, January 2024, and January 2025. Following this transaction, the reporting person beneficially owns 21,321 shares of Cohen & Steers common stock in direct ownership form.

Cohen & Steers, Inc. (CNS) reported an insider equity award for its President and Chief Investment Officer on a Form 4. On 11/20/2025, the executive acquired 769 shares of common stock at a price of $0, increasing his directly held position to 144,543 shares.

The filing explains that these 769 shares represent dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend. They accrued on previously granted unvested restricted stock units from awards made in January 2022, January 2023, January 2024, and January 2025, reflecting routine compensation-linked accruals rather than an open-market purchase.

Cohen & Steers, Inc. (CNS) reported a routine insider equity award for one of its officers, who serves as GC, Secretary and EVP. On 11/20/2025, the officer acquired 223 shares of common stock at a price of $0 per share.

The filing explains that these shares represent dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend, accruing on unvested restricted stock units originally granted in January 2022, January 2023, January 2024 and January 2025. Following this transaction, the officer directly holds 68,390 shares of Cohen & Steers common stock.

Cohen & Steers, Inc. insider activity: A Form 4 reports transactions by a director and 10% owner of CNS, Martin Cohen. On 11/18/2025, 100,000 shares of common stock were disposed of at a price of $0 through a transaction coded "G", reflecting a gift from the Martin Cohen 2018 Revocable Trust, which then held 8,071,461 shares indirectly.

On the same day, the reporting person bought 50,000 shares at a weighted average price of $59.69. Additional open-market purchases followed: 22,633 shares on 11/19/2025 at $59.5, 14,659 shares on 11/19/2025 at $59.91, and 12,708 shares on 11/20/2025 at $60.83. After these purchases, the reporting person directly owned 949,205 common shares.

Cohen & Steers, Inc. (CNS) — Form 4 insider activity: Executive Chairman, Director, and 10% owner Robert H. Steers reported a series of open‑market purchases (code P) of CNS common stock on 11/03/2025, 11/04/2025, and 11/05/2025 at weighted average prices listed in the filing.

Through the Robert H. Steers 2018 Revocable Trust, purchases included 19,856 shares at $68.15, 1,294 at $68.66, 27,292 at $67.95, 642 at $68.39, and 19,329 at $67.61, with beneficial ownership shown as 7,128,497 shares following the last reported transaction. The Hilltop GST Non‑Exempt Descendants' Trust reported 17,200 shares at $68.21, 300 at $68.65, and 14,975 at $67.96, with 3,891,184 shares owned following the last entry.

Additional reported holdings include 805,920 shares by The Sunnyridge GST Exempt Family Trust, 334 shares by the Hamilton‑Steers 2017 Trust FB Robert H. Steers, and 139,747 shares held directly. Footnotes state Mr. Steers disclaims beneficial ownership of certain trust‑held shares except to the extent of his pecuniary interest.

Cohen & Steers (CNS): Executive Chairman and 10% owner Robert H. Steers reported multiple open‑market purchases of common stock on Oct 20–22, 2025, primarily through family trusts. Examples include the Robert H. Steers 2018 Revocable Trust buying 6,382 shares at a $69.50 weighted average and 5,557 shares at $71.30. The Hilltop GST Non‑Exempt Descendants' Trust reported buys such as 5,204 shares at $69.44 and 5,434 shares at $71.31. Post‑trade, indirect holdings shown include 7,060,084 shares (Revocable Trust) and 3,858,709 shares (Hilltop Trust).

Cohen & Steers, Inc. (CNS) insider transaction: The company’s Interim CFO and SVP reported an acquisition of 2,154 shares of common stock on 10/17/2025 at a reported price of $0, tied to a grant of restricted stock units (RSUs). Following the transaction, the reporting person beneficially owns 26,018 shares directly.

The RSUs vest ratably over four years. Any dividends paid on the common stock are paid as additional RSUs, and those dividend RSUs vest on the fourth anniversary of the original RSU grant date.

Reena Aggarwal, a director of Cohen & Steers, Inc. (CNS), reported a stock award transaction dated 10/01/2025. The filing shows acquisition of 423 shares of common stock resulting from restricted stock units granted by the issuer at a $0 per-share price, and the reporting person holds 16,185 shares following the transaction. The RSUs were 100% vested on the grant date, with the underlying shares to be delivered on the third anniversary of the grant date. The Form 4 was filed by one reporting person and signed on behalf of the reporting person by an attorney-in-fact on 10/03/2025.

Edmond D. Villani, a director of Cohen & Steers, Inc. (CNS), reported multiple equity transactions in early October 2025. On 10/01/2025 he was granted 423 restricted stock units that were 100% vested on the grant date and will be delivered on the third anniversary of the grant. On 10/03/2025 he reported transferring 4,589 shares to the Edmond Dennis Villani Revocable Trust and also a reportable acquisition showing the trust holds 30,259 shares. Following the transactions, Dr. Villani directly owned 5,021 shares and the trust held the stated indirect position. The filings were signed by an attorney-in-fact on 10/03/2025.

Connor Frank T, a director of Cohen & Steers, Inc. (CNS), reported a grant of 423 restricted stock units on 10/01/2025 that were 100% vested on the grant date. The Form 4 shows the RSUs were granted with a $0 price and that the related 423 shares will be delivered to the reporting person on the third anniversary of the grant date. After the reported transaction, the reporting person beneficially owns 23,155 shares of common stock. The filing was signed by an attorney-in-fact on 10/03/2025.

Martin Cohen, a Director and 10% owner of Cohen & Steers, Inc. (CNS), filed a Form 4 reporting changes in his beneficial ownership. The filing shows 8,171,461 shares of common stock held indirectly by the Martin Cohen 2018 Revocable Trust, of which Mr. Cohen disclaims beneficial ownership except to the extent of his pecuniary interest. On 10/01/2025 the filing records a transaction coded A for 423 restricted stock units (RSUs) granted at a $0 price; the RSUs are stated to be 100% vested on the grant date and will be delivered on the third anniversary of the grant date. The Form 4 also reports a disposition of 849,205 shares. The filing is signed by an attorney-in-fact on 10/03/2025.

Cohen & Steers director Dasha Smith was granted 423 restricted stock units (RSUs) on 10/01/2025. The RSUs were 100% vested at grant and will be delivered as 423 shares of common stock to the reporting person on the third anniversary of the grant date. Following the reported transaction, the reporting person is shown as beneficially owning 9,038 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 10/03/2025. The filing discloses no cash price for the grant and lists the ownership as direct.

Karen Wilson Thissen, a director of Cohen & Steers, Inc. (CNS), received an award of 423 restricted stock units on 10/01/2025. The filing shows the RSUs were 100% vested on the grant date and will be delivered in shares to Ms. Thissen Wilson on the third anniversary of the grant. The Form 4 reports an acquisition price of $0 for the award and that the reporting person beneficially owns 1,302 shares of common stock following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

The filing reports that Dolly Lisa, a director of Cohen & Steers, Inc. (CNS), was granted 423 restricted stock units (RSUs) on 10/01/2025. The RSUs were 100% vested on the grant date and are payable in shares on the third anniversary of the grant date, at which time 1,567 shares will be delivered to the reporting person. The reported transaction shows a grant price of $0, and the Form 4 was signed by an attorney-in-fact on 10/03/2025. The report discloses direct beneficial ownership following the transaction as 1,567 shares.